Boston, MA USA
Add to Favorites | Newsroom RSS | Share

Our News on Newswise

American Diabetes Association Presents Guidance on Managing Diabetes in Older Adults in Long-Term Care Facilities

087_munshi.jpg

To ensure that this population receives proper care, the American Diabetes Association has issued its first position statement to address the management of diabetes in long-term care facilities, which include assisted living, skilled nursing and...
2-Feb-2016 11:05 AM EST Add to Favorites

Brown University Medical School Philanthropy Leader John A. Perry Joins Joslin Diabetes Center as Chief Development Officer

JohnPerryPhoto12-22-15_2.jpg

Joslin Diabetes Center, the, the world-renowned diabetes expert, has appointed John A. Perry, CFRE, a skilled fundraising professional with extensive experience in healthcare philanthropy, as Chief Development Officer effective February 1.
2-Feb-2016 11:05 AM EST Add to Favorites

Joslin Diabetes Center’s Dr. Lori Laffel, Chief of Pediatrics, Named 2016 Pinnacle Award Honoree for Achievement in the Professions

LoriLaffelMDMPH.jpg

The Greater Boston Chamber of Commerce has awarded Lori Laffel, M.D., MPH, Chief of the Pediatric, Adolescent and Young Adult Section at Joslin Diabetes Center and Professor of Pediatrics at Harvard Medical School, the Achievement in the Professions...
26-Jan-2016 11:05 AM EST Add to Favorites

C. Ronald Kahn, M.D., Is Awarded the Prestigious Wolf Prize in Medicine for Groundbreaking Research in Insulin Signaling

kahn24.jpg

The Wolf Foundation announced earlier this week that it has awarded the Wolf Prize in Medicine to C. Ronald Kahn, M.D., Chief Academic Officer and Senior Investigator at Joslin Diabetes Center and the Mary K. Iacocca Professor of Medicine at Harvard...
19-Jan-2016 11:05 AM EST Add to Favorites

Liver Protein Boosts Growth of Insulin-Producing Cells

Rohit_Kulkarni_MD_PhD.jpg

Now researchers at Joslin Diabetes Center have identified a key protein produced in the liver that aids in accelerating the growth of these cells.
8-Dec-2015 12:00 PM EST Add to Favorites

Lucentis Proves Effective Against Proliferative Diabetic Retinopathy

LPAiello_4094b.jpg

A clinical trial among more than 300 patients has found that the drug ranibizumab (Lucentis) is highly effective in treating proliferative diabetic retinopathy (PDR), a complication of diabetes that can severely damage eyesight.
10-Nov-2015 2:05 PM EST Add to Favorites

Joslin Chief Academic Officer Dr. C. Ronald Kahn Is Awarded The Harold Hamm International Prize for Biomedical Research in Diabetes

kahn19.jpg

The Harold Hamm Diabetes Center at the University of Oklahoma awarded C. Ronald Kahn, M.D., Chief Academic Officer and Senior Investigator at Joslin Diabetes Center and the Mary K. Iacocca Professor of Medicine at Harvard Medical School, the Harold...
5-Nov-2015 2:05 PM EST Add to Favorites

Joslin Diabetes Center Names Peter S. Amenta, M.D., Ph.D., as President and Chief Executive

PeterS.AmentaMDPhDPresidentCEOJoslinDiabetesCenter.jpg

Dr. Peter Amenta has been named President and CEO of Joslin Diabetes Center. Joslin Diabetes Center has 300 scientists working toward a cure for diabetes and its complications. Each year more than 100 clinical trials and human subject studies are...
16-Sep-2015 8:00 AM EDT Add to Favorites

Our Experts on Newswise

Dr. Lori Laffel, Chief of Pediatrics at Joslin Diabetes Center, Available to Comment on Type 1 Diabetes and Life Expectancy Studies

Laffel21.jpg

6-Jan-2015 11:00 AM EST

Back to School with Dr. Lori Laffel from Joslin Diabetes Center

laffel28.jpg

Lori Laffel, M.D., MPH, Chief of the Pediatric, Adolescent and Young Adult Section at Joslin Diabetes Center and Associate Professor of Pediatrics at Harvard Medical School, oversees the largest pediatric diabetes clinic in New England has over 25...
15-Aug-2014 8:00 AM EDT

Joslin Diabetes Center’s Cathy Carver Deciphers the ACA for People with Diabetes

Cathy-Carver.JPG

13-Nov-2013 1:00 PM EST

Expert Available: Bariatric Surgery for Diabetes

The International Diabetes Federation now recommends that surgery be considered as a treatment for obese patients with type 2 diabetes. Dr. Allison Goldfine, head of clinical research at Joslin Diabetes Center, is available for comment.
29-Mar-2011 9:00 AM EDT

Q&A: Howard Wolpert, M.D., and the Quest for an Artificial Pancreas

Howard_Wolpert_of_Joslin_Diabetes_Center.JPG

Emerging technologies such as continuous glucose monitoring (CGM) are helping people with type 1 diabetes manage their condition—what are the next steps? Howard Wolpert, M.D., of Joslin Diabetes Center discusses his current research and the global...
1-Oct-2010 1:00 PM EDT

Our YouTube Videos